An investigational medicine called zuranolone has generated significant, rapid, and enduring symptom reduction in women with postpartum depression . The...
Read More
Is it possible to disrupt the process by which a mother can transmit risk for psychiatric disorders to her offspring?...
Read More
Past research has established a clear connection between maternal depression and risk of adverse outcomes in newborns, for instance a...
Read More
On March 19, 2019, the U.S. Food and Drug Administration approved the first-ever drug specifically designed to alleviate the symptoms...
Read More
During pregnancy and for some time after giving birth, a woman’s immune response in the brain may be tuned down,...
Read More